Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

Analysis of Profitability Ratios
Quarterly Data

Microsoft Excel

Profitability Ratios (Summary)

CVS Health Corp., profitability ratios (quarterly data)

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Return on Sales
Gross profit margin 13.81% 14.37% 14.55% 14.94% 15.34% 15.69% 16.16% 16.62% 16.94% 17.12% 17.35% 17.48% 17.35% 17.43% 17.99% 18.01% 18.10% 18.16% 17.51% 17.41%
Operating profit margin 2.59% 3.42% 3.49% 3.85% 4.04% 1.88% 2.33% 2.41% 2.02% 4.35% 4.39% 4.54% 4.75% 4.93% 5.19% 5.19% 5.44% 5.36% 4.89% 4.69%
Net profit margin 1.37% 1.99% 2.04% 2.34% 2.48% 0.86% 1.20% 1.29% 1.00% 2.66% 2.68% 2.72% 2.67% 2.60% 2.74% 2.68% 3.00% 3.14% 2.77% 2.59%
Return on Investment
Return on equity (ROE) 6.69% 9.60% 9.90% 10.91% 11.57% 4.02% 5.57% 5.84% 4.46% 10.86% 10.83% 10.54% 10.20% 9.83% 10.44% 10.35% 11.56% 12.14% 11.08% 10.39%
Return on assets (ROA) 1.99% 2.85% 2.93% 3.34% 3.42% 1.17% 1.66% 1.82% 1.36% 3.55% 3.43% 3.39% 3.23% 3.12% 3.22% 3.11% 3.41% 3.51% 3.13% 2.98%

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. CVS Health Corp. gross profit margin ratio deteriorated from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. CVS Health Corp. operating profit margin ratio deteriorated from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. CVS Health Corp. net profit margin ratio deteriorated from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. CVS Health Corp. ROE deteriorated from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
ROA A profitability ratio calculated as net income divided by total assets. CVS Health Corp. ROA deteriorated from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.

Gross Profit Margin

CVS Health Corp., gross profit margin calculation (quarterly data)

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selected Financial Data (US$ in millions)
Gross profit 12,008 12,989 12,107 13,608 13,300 13,329 13,041 13,490 13,174 13,594 13,198 13,285 12,456 12,906 12,202 11,709 11,516 13,164 11,859 11,485 11,260 11,081 10,691
Revenues from customers 94,878 90,840 87,983 93,545 89,487 88,647 84,944 83,523 80,958 80,490 76,658 76,237 73,548 72,327 68,800 69,306 66,852 65,157 66,593 66,683 64,547 63,138 61,397
Profitability Ratio
Gross profit margin1 13.81% 14.37% 14.55% 14.94% 15.34% 15.69% 16.16% 16.62% 16.94% 17.12% 17.35% 17.48% 17.35% 17.43% 17.99% 18.01% 18.10% 18.16% 17.51% 17.41%
Benchmarks
Gross Profit Margin, Competitors2
Abbott Laboratories 50.96% 50.53% 50.27% 50.28% 49.97% 50.23% 50.66% 51.54% 52.60% 53.54% 52.44% 52.21% 52.01% 50.69% 51.25% 50.49% 50.18% 50.97% 52.13% 52.46%
Cigna Group 10.83% 11.41% 11.90% 12.37% 12.28% 12.19% 12.39% 12.44% 12.39% 12.40% 12.30% 12.41% 12.77% 13.13% 14.04% 14.43% 15.05% 15.49% 15.30% 15.57%
Elevance Health Inc. 16.62% 17.16% 16.92% 16.79% 16.86% 16.89% 16.90% 16.79% 16.85% 16.79% 16.89% 17.09% 17.30% 17.57% 19.38% 19.71% 20.18% 20.43% 18.70% 18.77%
Intuitive Surgical Inc. 66.98% 66.86% 66.43% 66.39% 66.61% 66.74% 66.86% 67.44% 67.77% 68.16% 68.84% 69.32% 69.12% 68.69% 66.48% 65.65% 66.44% 67.07% 69.04% 69.45%
Medtronic PLC 65.50% 65.40% 65.68% 65.67% 66.43% 67.21% 67.61% 67.98% 67.89% 67.39% 66.53% 65.19% 63.85% 64.57% 65.76% 67.41% 68.96% 69.22% 69.62% 70.04%
UnitedHealth Group Inc. 21.91% 22.63% 23.18% 23.64% 24.16% 24.08% 24.20% 24.09% 23.74% 23.51% 23.31% 23.60% 23.75% 23.80% 25.79% 25.62% 25.83% 25.95% 23.52% 23.19%

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

1 Q3 2024 Calculation
Gross profit margin = 100 × (Gross profitQ3 2024 + Gross profitQ2 2024 + Gross profitQ1 2024 + Gross profitQ4 2023) ÷ (Revenues from customersQ3 2024 + Revenues from customersQ2 2024 + Revenues from customersQ1 2024 + Revenues from customersQ4 2023)
= 100 × (12,008 + 12,989 + 12,107 + 13,608) ÷ (94,878 + 90,840 + 87,983 + 93,545) = 13.81%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. CVS Health Corp. gross profit margin ratio deteriorated from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.

Operating Profit Margin

CVS Health Corp., operating profit margin calculation (quarterly data)

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selected Financial Data (US$ in millions)
Operating income (loss) 832 3,045 2,271 3,373 3,690 3,234 3,446 3,618 (3,931) 4,569 3,490 2,229 3,061 4,326 3,577 2,524 3,249 4,680 3,458 3,037 2,928 3,332 2,690
Revenues from customers 94,878 90,840 87,983 93,545 89,487 88,647 84,944 83,523 80,958 80,490 76,658 76,237 73,548 72,327 68,800 69,306 66,852 65,157 66,593 66,683 64,547 63,138 61,397
Profitability Ratio
Operating profit margin1 2.59% 3.42% 3.49% 3.85% 4.04% 1.88% 2.33% 2.41% 2.02% 4.35% 4.39% 4.54% 4.75% 4.93% 5.19% 5.19% 5.44% 5.36% 4.89% 4.69%
Benchmarks
Operating Profit Margin, Competitors2
Abbott Laboratories 16.24% 15.92% 15.76% 16.15% 15.02% 15.23% 16.77% 19.16% 20.95% 22.42% 20.73% 19.56% 20.04% 18.46% 17.97% 15.48% 13.39% 12.78% 14.18% 14.21%
Cigna Group 4.02% 4.14% 4.29% 4.40% 4.34% 4.38% 4.54% 4.69% 4.59% 4.71% 4.64% 4.60% 4.59% 4.57% 4.98% 5.12% 5.37% 5.47% 5.18% 5.31%
Elevance Health Inc. 4.55% 4.76% 4.64% 4.47% 4.58% 4.96% 4.99% 4.94% 5.01% 5.07% 5.10% 5.15% 4.91% 3.68% 4.83% 4.97% 5.59% 6.99% 5.47% 5.49%
Humana Inc. 2.42% 2.92% 3.27% 3.81% 4.42% 4.55% 4.45% 4.11% 4.09% 3.57% 3.73% 3.80% 3.40% 4.97% 6.60% 6.56% 7.77% 6.77% 5.09% 4.96%
Intuitive Surgical Inc. 26.24% 25.79% 25.26% 24.80% 24.66% 24.34% 24.21% 25.35% 27.05% 28.48% 30.69% 31.89% 32.55% 31.27% 26.01% 24.09% 23.95% 25.86% 30.52% 30.69%
Medtronic PLC 17.50% 17.41% 17.83% 17.56% 18.17% 19.02% 19.37% 18.15% 17.89% 16.68% 14.78% 14.89% 11.44% 12.77% 14.25% 16.57% 20.67% 20.47% 21.25% 20.51%
UnitedHealth Group Inc. 8.28% 8.40% 8.58% 8.80% 8.86% 8.83% 8.87% 8.83% 8.65% 8.32% 8.19% 8.40% 7.91% 7.73% 9.24% 8.76% 9.55% 9.89% 8.12% 8.19%

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

1 Q3 2024 Calculation
Operating profit margin = 100 × (Operating income (loss)Q3 2024 + Operating income (loss)Q2 2024 + Operating income (loss)Q1 2024 + Operating income (loss)Q4 2023) ÷ (Revenues from customersQ3 2024 + Revenues from customersQ2 2024 + Revenues from customersQ1 2024 + Revenues from customersQ4 2023)
= 100 × (832 + 3,045 + 2,271 + 3,373) ÷ (94,878 + 90,840 + 87,983 + 93,545) = 2.59%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. CVS Health Corp. operating profit margin ratio deteriorated from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.

Net Profit Margin

CVS Health Corp., net profit margin calculation (quarterly data)

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selected Financial Data (US$ in millions)
Net income (loss) attributable to CVS Health 87 1,770 1,113 2,046 2,261 1,901 2,136 2,302 (3,416) 2,951 2,312 1,306 1,598 2,783 2,223 973 1,224 2,975 2,007 1,747 1,530 1,936 1,421
Revenues from customers 94,878 90,840 87,983 93,545 89,487 88,647 84,944 83,523 80,958 80,490 76,658 76,237 73,548 72,327 68,800 69,306 66,852 65,157 66,593 66,683 64,547 63,138 61,397
Profitability Ratio
Net profit margin1 1.37% 1.99% 2.04% 2.34% 2.48% 0.86% 1.20% 1.29% 1.00% 2.66% 2.68% 2.72% 2.67% 2.60% 2.74% 2.68% 3.00% 3.14% 2.77% 2.59%
Benchmarks
Net Profit Margin, Competitors2
Abbott Laboratories 13.99% 13.65% 13.96% 14.27% 12.92% 12.83% 13.98% 15.88% 17.52% 18.78% 17.35% 16.42% 17.12% 15.85% 15.33% 12.99% 10.50% 9.89% 11.15% 11.56%
Cigna Group 1.31% 1.71% 1.77% 2.66% 2.81% 3.59% 3.71% 3.72% 3.69% 3.08% 3.07% 3.11% 4.97% 4.93% 5.22% 5.31% 3.40% 3.43% 3.22% 3.35%
Elevance Health Inc. 3.72% 3.93% 3.66% 3.52% 3.63% 3.89% 3.89% 3.87% 4.09% 4.13% 4.37% 4.46% 4.17% 3.32% 3.82% 3.78% 4.26% 5.27% 4.42% 4.66%
Humana Inc. 1.19% 1.54% 1.84% 2.36% 2.97% 3.45% 3.28% 3.03% 3.07% 3.52% 3.52% 3.54% 3.31% 3.13% 4.78% 4.43% 5.67% 5.00% 3.89% 4.20%
Intuitive Surgical Inc. 28.51% 27.65% 27.16% 25.24% 22.14% 21.38% 20.40% 21.25% 22.52% 24.05% 27.84% 29.85% 30.78% 31.43% 25.78% 24.33% 24.45% 26.07% 30.11% 30.80%
Medtronic PLC 13.00% 12.84% 11.47% 12.03% 13.20% 14.03% 16.75% 15.90% 15.46% 14.79% 12.29% 11.97% 10.36% 12.69% 15.80% 16.56% 17.11% 15.11% 14.41% 15.16%
UnitedHealth Group Inc. 3.68% 3.70% 4.09% 6.09% 6.09% 6.11% 6.21% 6.25% 6.21% 5.99% 5.91% 6.06% 5.56% 5.37% 6.46% 6.03% 6.66% 6.94% 5.63% 5.76%

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

1 Q3 2024 Calculation
Net profit margin = 100 × (Net income (loss) attributable to CVS HealthQ3 2024 + Net income (loss) attributable to CVS HealthQ2 2024 + Net income (loss) attributable to CVS HealthQ1 2024 + Net income (loss) attributable to CVS HealthQ4 2023) ÷ (Revenues from customersQ3 2024 + Revenues from customersQ2 2024 + Revenues from customersQ1 2024 + Revenues from customersQ4 2023)
= 100 × (87 + 1,770 + 1,113 + 2,046) ÷ (94,878 + 90,840 + 87,983 + 93,545) = 1.37%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. CVS Health Corp. net profit margin ratio deteriorated from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.

Return on Equity (ROE)

CVS Health Corp., ROE calculation (quarterly data)

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selected Financial Data (US$ in millions)
Net income (loss) attributable to CVS Health 87 1,770 1,113 2,046 2,261 1,901 2,136 2,302 (3,416) 2,951 2,312 1,306 1,598 2,783 2,223 973 1,224 2,975 2,007 1,747 1,530 1,936 1,421
Total CVS Health shareholders’ equity 74,944 74,930 73,968 76,461 74,337 72,726 71,382 71,015 70,683 75,184 73,830 75,075 74,308 73,244 70,850 69,389 68,807 68,022 65,140 63,864 62,614 61,282 59,686
Profitability Ratio
ROE1 6.69% 9.60% 9.90% 10.91% 11.57% 4.02% 5.57% 5.84% 4.46% 10.86% 10.83% 10.54% 10.20% 9.83% 10.44% 10.35% 11.56% 12.14% 11.08% 10.39%
Benchmarks
ROE, Competitors2
Abbott Laboratories 14.49% 14.13% 14.51% 14.83% 13.77% 13.88% 15.68% 18.90% 22.11% 23.44% 21.82% 19.75% 21.04% 18.86% 17.06% 13.71% 10.78% 10.17% 11.84% 11.86%
Cigna Group 7.22% 8.97% 8.79% 11.17% 11.61% 14.64% 15.17% 14.86% 14.69% 11.94% 11.69% 11.39% 17.68% 16.73% 17.52% 16.81% 11.03% 11.11% 10.91% 11.26%
Elevance Health Inc. 14.66% 15.86% 15.38% 15.23% 15.82% 16.78% 16.62% 16.59% 17.26% 17.04% 17.36% 16.93% 15.44% 12.10% 13.92% 13.77% 14.61% 17.17% 15.08% 15.15%
Humana Inc. 7.74% 10.26% 12.34% 15.31% 17.79% 20.07% 18.79% 18.33% 17.27% 20.29% 19.81% 18.24% 16.44% 16.72% 26.23% 24.53% 26.34% 24.29% 21.16% 22.49%
Intuitive Surgical Inc. 14.39% 14.23% 14.24% 13.51% 12.10% 12.00% 11.70% 11.98% 11.97% 11.93% 13.58% 14.32% 14.80% 14.97% 11.56% 10.90% 11.38% 13.00% 16.30% 16.69%
Medtronic PLC 8.11% 7.97% 7.07% 7.30% 7.90% 8.33% 9.88% 9.59% 9.35% 9.05% 7.54% 7.01% 5.70% 7.05% 8.77% 9.44% 10.26% 9.23% 8.78% 9.25%
UnitedHealth Group Inc. 15.14% 15.78% 17.72% 25.22% 25.67% 25.63% 25.46% 25.87% 26.03% 25.07% 23.98% 24.09% 21.95% 21.03% 25.42% 23.52% 25.65% 26.87% 24.14% 24.02%

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

1 Q3 2024 Calculation
ROE = 100 × (Net income (loss) attributable to CVS HealthQ3 2024 + Net income (loss) attributable to CVS HealthQ2 2024 + Net income (loss) attributable to CVS HealthQ1 2024 + Net income (loss) attributable to CVS HealthQ4 2023) ÷ Total CVS Health shareholders’ equity
= 100 × (87 + 1,770 + 1,113 + 2,046) ÷ 74,944 = 6.69%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. CVS Health Corp. ROE deteriorated from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.

Return on Assets (ROA)

CVS Health Corp., ROA calculation (quarterly data)

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selected Financial Data (US$ in millions)
Net income (loss) attributable to CVS Health 87 1,770 1,113 2,046 2,261 1,901 2,136 2,302 (3,416) 2,951 2,312 1,306 1,598 2,783 2,223 973 1,224 2,975 2,007 1,747 1,530 1,936 1,421
Total assets 252,427 252,481 249,743 249,728 251,306 250,071 239,330 228,275 231,212 230,279 232,873 232,999 234,891 231,164 229,606 230,715 232,898 235,495 230,639 222,449 220,113 218,904 219,768
Profitability Ratio
ROA1 1.99% 2.85% 2.93% 3.34% 3.42% 1.17% 1.66% 1.82% 1.36% 3.55% 3.43% 3.39% 3.23% 3.12% 3.22% 3.11% 3.41% 3.51% 3.13% 2.98%
Benchmarks
ROA, Competitors2
Abbott Laboratories 7.76% 7.61% 7.77% 7.82% 7.16% 7.04% 7.87% 9.31% 10.84% 11.53% 10.44% 9.40% 9.82% 8.70% 7.86% 6.20% 4.90% 4.52% 5.36% 5.43%
Cigna Group 1.93% 2.39% 2.36% 3.38% 3.54% 4.43% 4.56% 4.63% 4.59% 3.59% 3.53% 3.46% 5.44% 5.29% 5.55% 5.44% 3.31% 3.30% 3.18% 3.28%
Elevance Health Inc. 5.51% 5.92% 5.58% 5.50% 5.50% 5.87% 5.69% 5.86% 6.03% 6.05% 6.21% 6.26% 5.63% 4.40% 4.93% 5.28% 5.72% 6.72% 5.80% 6.21%
Humana Inc. 2.72% 3.42% 3.97% 5.29% 5.39% 5.98% 5.69% 6.52% 5.53% 6.71% 6.55% 6.61% 5.90% 6.52% 9.95% 9.63% 10.79% 9.11% 7.55% 9.31%
Intuitive Surgical Inc. 12.64% 12.57% 12.56% 11.64% 10.31% 10.25% 10.05% 10.19% 10.39% 10.47% 12.02% 12.58% 13.06% 13.20% 10.17% 9.50% 9.92% 11.24% 14.02% 14.17%
Medtronic PLC 4.63% 4.55% 3.99% 4.13% 4.32% 4.63% 5.79% 5.54% 5.35% 5.13% 4.23% 3.87% 2.97% 3.69% 4.70% 5.28% 5.73% 5.13% 4.84% 5.16%
UnitedHealth Group Inc. 4.78% 4.93% 5.40% 8.18% 7.69% 7.53% 7.30% 8.19% 7.99% 7.93% 7.89% 8.15% 7.24% 6.90% 8.23% 7.81% 8.76% 8.88% 7.27% 7.96%

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

1 Q3 2024 Calculation
ROA = 100 × (Net income (loss) attributable to CVS HealthQ3 2024 + Net income (loss) attributable to CVS HealthQ2 2024 + Net income (loss) attributable to CVS HealthQ1 2024 + Net income (loss) attributable to CVS HealthQ4 2023) ÷ Total assets
= 100 × (87 + 1,770 + 1,113 + 2,046) ÷ 252,427 = 1.99%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. CVS Health Corp. ROA deteriorated from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.